Press Releases

Creative Diagnostics Offers High-quality Magnetic Silica Particles for DNA & RNA Isolation

Creative Diagnostics has released high-quality magnetic silica particles for the isolation of nucleic acid (DNA, RNA) as well as large versus small fragments from various kinds of body fluids, which just takes 3 seconds for complete separation.

Absolute Antibody Offers SARS-CoV-2 Neutralizing Antibodies Derived from COVID-19 Patients

BOC Sciences Released A New Antibody-drug Conjugate Technology Platform

CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection

CD Genomics Releases Oral Sample Collection Products to Help the Collection and Preservation of Oral Cells

Creative Enzymes Introduces Biocatalysis Services for Process of Biocatalyst Development

Accumen Releases First FDA EUA COVID-19 Saliva Testing Kits

Accumen Inc. is partnering with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally.

Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer

Panthera’s UK oncology clinical trial sites open for studies

Panthera's UK oncology clinical trial sites are open despite 1000+ international cancer trials being suspended due to COVID-19.

CD Genomics Announces Advanced CDAMP® Panel Kits for SARS-CoV-2 Detection

CD Genomics Launches Complete Product Portfolio for Research to COVID-19 Response

Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling

Cell-Based Solutions for Tumor Research Are Available by Creative Proteomics’s Tumomics Platform

Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions

UK medtech firm awarded government grants to aid Covid-19 test development

UK medtech firm Bond Digital Health has received more than £200,000 in government grants to help it develop its connectivity and data platform for a new Covid-19 test. The Cardiff, Wales-based company was awarded two major grants in the space of a month for its innovative Transform technology - £177,979 from the Welsh Government and £49,796 from Innovate UK, the UK’s national innovation agency.

Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services

Creative Proteomics Launches Untargeted Metabolomics Services for Drug Development

Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time. The dashboard is automatically created by the dispensing of the pill/tablet through the intelligent Pill Connect cap which fits on any standard pill bottle. The patient receives a reminder on their phone when the pill or pills should be taken. The patient then touches the dispense button on the screen and the pill is ejected from the bottle and a signal is sent, via the phone, that the pill has been dispensed.

Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases

Quantabio's UltraPlex 1-Step ToughMix was recognized as part of the new EUA for the CDC) Influenza SARS-CoV-2 (Flu SC2 Multiplex Assay.

VERICHEM LABORATORIES OFFERS FREE, CLIA COMPLIANT, WEB-BASED CALIBRATION VERIFICATION DATA REDUCTION SERVICES

VERICHEM LABORATORIES now offers all its customers free access to the company’s online, web-based, data reduction services that supports all necessary statistics required within the clinical laboratory to satisfy current CLIA and CAP requirements for the calibration verification of clinical assays.